Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

When Stuart Haxell, who has spent the last 12 years functionally blind, was shown a letter on a page after receiving ...

A 31-year-old Sligo man who was functionally blind has got his sight back, after being treated with a new gene therapy at the ...

An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...

Revolutionary gene therapy approaches show promise in treating various retinal conditions, potentially transforming treatment ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

YolTech's gene therapy is intended as a one-time life-long cure for patients living with PH1, which can lead to kidney ...